Similar articles

• Thrombolytic agents for acute evolving myocardial infarction: comparative effects.

  Sherry S. Sherry S. Ration Drug Ther. 1987 Jan;21(1):1-9. Ration Drug Ther. 1987. PMID: 3112866 No abstract available.
• New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.

  Verstraete M. Verstraete M. Circulation. 1987 Aug;76(2 Pt 2):II31-8. Circulation. 1987. PMID: 3111745 Review. No abstract available.
• [New thrombolytic agents in myocardial infarction].

  Charbonnier B, Lang M, Brochier M. Charbonnier B, et al. Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91. Arch Mal Coeur Vaiss. 1987. PMID: 3128222 Review. French.
• Coronary thrombolysis with clot-selective plasminogen activators.

  Collen D, Bounameaux H. Collen D, et al. Herz. 1986 Feb;11(1):9-15. Herz. 1986. PMID: 3082731
• How should intravenous thrombolytic agents for acute myocardial infarction be selected?

  Topol EJ. Topol EJ. Cardiovasc Clin. 1990;21(1):57-75; discussion 76-8. Cardiovasc Clin. 1990. PMID: 2143103 No abstract available.